WAVEMAN · COMPANY

ALMR · Alamar Biosciences, Inc.

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475

← ALL COMPANIES

ALMR

Name: Alamar Biosciences, Inc. (ALMR) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Alamar Biosciences, Inc.

MEDICAL DEVICES · LABORATORY ANALYTICAL INSTRUMENTS · CIK 0002104204

ACTIVIST 13D☆ WATCH

INSIDER NET · 180D

$8.0M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+82.1%

XBRL, annual

NET MARGIN

-44.9%

CONVERSIONS · 180D

codes C/M, not in net · no price filed

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$8.0M over 180 days

+$4.0M of it by a 10%+ holder

more than 97% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

87 funds added or opened last quarter

more than 54% of Medical Devices

REVENUE

+82.1% year over year (latest quarter)

more than 92% of Medical Devices

MARGIN

-44.9% net margin (latest quarter)

below 72% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

3.5% of shares outstanding short · 11.3 days to cover · settled 2026-07-31

more than 50% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

87 funds added or opened positions in the latest 13F quarter, of 87 holders.

Illumina Innovation Fund II GP, L.L.C. disclosed a 5%+ stake (8.8%) in the last six months.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +39.0%

+39.0%12M

INSIDER BUY13D/G STAKE

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

An activist crossed the 5% line with declared intent.

The record shows a net $8.0M bought by insiders over 180 days, 87 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Alamar Biosciences, Inc. insiders bought a net $8.0M of stock across 2 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER

FILED

VALUE

Illumina Innovation Fund II GP, L.L.C.

—

BUY

2026-04-20

235,294.0

$4.0M

Naclerio Nicholas

Director

BUY

2026-04-20

235,294.0

$4.0M

2 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Sands Capital Alternatives, LLC

4,230,926.0 sh

$114.6M

SAMSARA BIOCAPITAL, LLC

2,480,310.0 sh

$67.2M

ARK Investment Management LLC

1,373,959.0 sh

$37.2M

BRAIDWELL LP

1,083,983.0 sh

$29.4M

ALLIANCEBERNSTEIN L.P.

1,003,077.0 sh

$27.2M

5%+ owners

13D = intent to influence · 13G = passive

Illumina Innovation Fund II GP, L.L.C.

ACTIVIST 13D · 2026-04-23

8.8%

Illumina Innovation Fund II, L.P.

ACTIVIST 13D · 2026-04-23

8.8%

Illumina Innovation Fund III GP, L.L.C.

ACTIVIST 13D · 2026-04-23

0.8%

Illumina Innovation Fund III, L.P.

ACTIVIST 13D · 2026-04-23

0.8%

Nicholas Naclerio

ACTIVIST 13D · 2026-04-23

9.6%

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

ARK Genomic Revolution ETF

$14.9M POSITION · AS OF 2026-04-30

1.2%

AB Small Cap Growth Portfolio

$10.4M POSITION · AS OF 2026-04-30

0.4%

Lord Abbett Micro-Cap Growth Fund

$717.4K POSITION · AS OF 2026-04-30

0.4%

Emerald Growth Fund

$3.9M POSITION · AS OF 2026-04-30

0.3%

SmallCap Growth Fund I

$5.3M POSITION · AS OF 2026-04-30

0.2%

Fidelity Advisor Health Care Fund

$4.2M POSITION · AS OF 2026-04-30

0.1%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK